No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3′flanking region of the interleukin-6 gene in patients with multiple sclerosis
References (16)
- et al.
Polymorphisms of the interleukin-6 gene are associated with bone mineral density
Bone
(1997) - et al.
Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis
J. Neuroimmunol.
(1996) - et al.
CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis
J. Neuroimmunol.
(1999) - et al.
Rapid detection and sequencing of alleles in the 3′flanking region of the interleukin-6 gene
Nucleic Acids Res.
(1989) - et al.
The 3′untranslated region of messenger RNA: a molecular hotspot for pathology?
Nat. Med.
(2000) - et al.
Genetics of multiple sclerosis
Semin. Neurol.
(1998) - et al.
IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
Eur. J. Immunol.
(1998) - et al.
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and serum levels, and an association with systemic-onset juvenile chronic arthritis,
J. Clin. Invest.
(1998)
There are more references available in the full text version of this article.
Cited by (12)
Genetics of interleukin 6: Implications for Alzheimer's disease
2001, Neurobiology of AgingThe -174/ - 597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis
2001, Journal of the Neurological SciencesSystems Biology for Traditional Chinese Medicine
2012, Systems Biology for Traditional Chinese MedicineInterleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians
2007, Annals of Human Genetics
Copyright © 2000 Elsevier Science Ireland Ltd. All rights reserved.